Prevendia

Prevendia is a Norwegian biotechnology company specializing in the early detection of life-threatening diseases, with a primary focus on oncology. The company utilizes a proprietary platform that combines advanced protein analysis with artificial intelligence and machine learning to identify specific biomarker patterns in blood samples. By detecting diseases at a pre-symptomatic stage, Prevendia aims to significantly improve patient outcomes and survival rates through early intervention. Their lead development programs are focused on the early identification of lung and colorectal cancers using non-invasive liquid biopsy techniques.